Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2009
Home
2009
November 19, 2019
Published by
Tiffany McMillan
on
November 19, 2019
Categories
Important European Patent Granted
November 19, 2019
Published by
Tiffany McMillan
on
November 19, 2019
Categories
Appendix 4E & Annual Financial Report
November 19, 2019
Published by
Tiffany McMillan
on
November 19, 2019
Categories
Midkine combination test superior to conventional cancer markers
November 19, 2019
Published by
Tiffany McMillan
on
November 19, 2019
Categories
Agreement signed with Kumamoto University
November 19, 2019
Published by
Tiffany McMillan
on
November 19, 2019
Categories
Appointment of non-executive Director
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Agreement signed with Kumamoto University
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Appointment of non-executive Director
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Notice of Meeting/Proxy Form
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Lung Cancer Diagnostic License signed with Celera
Prev page
1
2
3
4
5
6
Next page
